From BBC News · · 1m 10s
Kennedy plans to loosen rules on unapproved peptides
US Health Secretary Robert F Kennedy Jr announces plans to allow compounding pharmacies to prepare six peptides not approved by the FDA, reversing the Biden administration's restrictions.
In brief
US Health Secretary Robert F Kennedy Jr announces plans to allow compounding pharmacies to prepare six peptides not approved by the FDA, reversing the Biden administration's restrictions. Health Secretary Robert F Kennedy Jr announced plans to loosen FDA restrictions on six unapproved peptides, allowing compounding…
Kennedy announces peptide plan
US Health Secretary Robert F Kennedy Jr released plans on Wednesday to loosen restrictions on six controversial peptides not approved by the Food and Drug Administration.
What the plan allows
The plan would allow compounding pharmacies to prepare BPC-157, TB-500, KPV, MOTS-c and Semax. The draft came from Kennedy's office rather than the FDA, unusually.
Expert warnings about safety
Health experts have cautioned against the peptides, citing a lack of clinical trials for humans and unknown long-term effects. Unregulated peptides have become popular online and among teens on TikTok.
What happens next
After official publication later this week, there will be a two-week public comment period. An FDA advisory panel voted in July to loosen restrictions, but FDA staff recommended against it.
What it means
Health Secretary Robert F Kennedy Jr announced plans to loosen FDA restrictions on six unapproved peptides, allowing compounding pharmacies to prepare them despite expert warnings about safety.
